302 related articles for article (PubMed ID: 12067854)
1. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men.
Roubenoff R; Grinspoon S; Skolnik PR; Tchetgen E; Abad L; Spiegelman D; Knox T; Gorbach S
Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E138-45. PubMed ID: 12067854
[TBL] [Abstract][Full Text] [Related]
2. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
3. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
Gelato M; McNurlan M; Freedland E
Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and predictors of HIV-associated weight loss in the era of highly active antiretroviral therapy.
Batterham MJ; Garsia R; Greenop P
Int J STD AIDS; 2002 Nov; 13(11):744-7. PubMed ID: 12437893
[TBL] [Abstract][Full Text] [Related]
5. How relevant are cytokines in colorectal cancer wasting?
Ravasco P; Monteiro-Grillo I; Camilo M
Cancer J; 2007; 13(6):392-8. PubMed ID: 18032977
[TBL] [Abstract][Full Text] [Related]
6. Total energy expenditure and carbohydrate oxidation are increased in the human immunodeficiency virus lipodystrophy syndrome.
Kosmiski LA; Kuritzkes DR; Sharp TA; Hamilton JT; Lichtenstein KA; Mosca CL; Grunwald GK; Eckel RH; Hill JO
Metabolism; 2003 May; 52(5):620-5. PubMed ID: 12759894
[TBL] [Abstract][Full Text] [Related]
7. Increased resting energy expenditure in hemodialysis patients with severe hyperparathyroidism.
Cuppari L; de Carvalho AB; Avesani CM; Kamimura MA; Dos Santos Lobão RR; Draibe SA
J Am Soc Nephrol; 2004 Nov; 15(11):2933-9. PubMed ID: 15504947
[TBL] [Abstract][Full Text] [Related]
8. Changes in weight and lean body mass during highly active antiretroviral therapy.
Shikuma CM; Zackin R; Sattler F; Mildvan D; Nyangweso P; Alston B; Evans S; Mulligan K;
Clin Infect Dis; 2004 Oct; 39(8):1223-30. PubMed ID: 15486848
[TBL] [Abstract][Full Text] [Related]
9. Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy.
Mwamburi DM; Wilson IB; Jacobson DL; Spiegelman D; Gorbach SL; Knox TA; Wanke CA
Clin Infect Dis; 2005 Jan; 40(1):167-73. PubMed ID: 15614708
[TBL] [Abstract][Full Text] [Related]
10. Calculating energy requirements for men with HIV/AIDS in the era of highly active antiretroviral therapy.
Batterham MJ; Morgan-Jones J; Greenop P; Garsia R; Gold J; Caterson I
Eur J Clin Nutr; 2003 Feb; 57(2):209-17. PubMed ID: 12571651
[TBL] [Abstract][Full Text] [Related]
11. Energy expenditure and wasting in human immunodeficiency virus infection.
Macallan DC; Noble C; Baldwin C; Jebb SA; Prentice AM; Coward WA; Sawyer MB; McManus TJ; Griffin GE
N Engl J Med; 1995 Jul; 333(2):83-8. PubMed ID: 7777033
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated energy expenditure in HIV-infected patients: a mechanistic review.
Chang E; Sekhar R; Patel S; Balasubramanyam A
Clin Infect Dis; 2007 Jun; 44(11):1509-17. PubMed ID: 17479951
[TBL] [Abstract][Full Text] [Related]
13. HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages?
Shikuma CM; Valcour VG; Ratto-Kim S; Williams AE; Souza S; Gerschenson M; Day L; Kim JH; Shiramizu B
Clin Infect Dis; 2005 Jun; 40(12):1846-8. PubMed ID: 15909275
[TBL] [Abstract][Full Text] [Related]
14. Serum dihydrotestosterone and testosterone concentrations in human immunodeficiency virus-infected men with and without weight loss.
Arver S; Sinha-Hikim I; Beall G; Guerrero M; Shen R; Bhasin S
J Androl; 1999; 20(5):611-8. PubMed ID: 10520573
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
[TBL] [Abstract][Full Text] [Related]
16. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy.
Silver HJ; Dietrich MS; Murphy BA
Head Neck; 2007 Oct; 29(10):893-900. PubMed ID: 17405169
[TBL] [Abstract][Full Text] [Related]
17. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia.
Metsios GS; Stavropoulos-Kalinoglou A; Douglas KM; Koutedakis Y; Nevill AM; Panoulas VF; Kita M; Kitas GD
Rheumatology (Oxford); 2007 Dec; 46(12):1824-7. PubMed ID: 18032540
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy.
Rietschel P; Corcoran C; Stanley T; Basgoz N; Klibanski A; Grinspoon S
Clin Infect Dis; 2000 Nov; 31(5):1240-4. PubMed ID: 11073758
[TBL] [Abstract][Full Text] [Related]
19. Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting.
Esposito JG; Thomas SG; Kingdon L; Ezzat S
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E494-503. PubMed ID: 15886228
[TBL] [Abstract][Full Text] [Related]
20. Body shape and composition in HIV-infected women: an urban cohort.
Karmon SL; Moore RD; Dobs AS; Keruly J; Barnett S; Cofrancesco J
HIV Med; 2005 Jul; 6(4):245-52. PubMed ID: 16011529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
